Mc-Val-Cit-PABC-PNP: Protocol Guidance for ADC Linker Use

What This Product Solves

Mc-Val-Cit-PABC-PNP is designed as a cathepsin B-cleavable ADC peptide linker for antibody-drug conjugate (ADC) workflows. Its utility lies in enabling selective lysosomal release of cytotoxic payloads once internalized by target cells, a critical mechanism for enhancing specificity in targeted drug delivery research. The use of a cathepsin B substrate linker, such as Mc-Val-Cit-PABC-PNP, is essential in constructing ADCs where payload activation must occur only after cellular uptake and trafficking to the lysosome. This approach minimizes off-target toxicity compared to non-cleavable linkers and supports the development of ADCs similar to FDA-approved agents like brentuximab vedotin. Researchers working in ADC design, especially those prioritizing lysosomal cleavage and organic-soluble workflows, will find Mc-Val-Cit-PABC-PNP highly relevant. For more details, refer to the Mc-Val-Cit-PABC-PNP product page.

For an in-depth perspective on the chemical basis of lysosomal cleavage and best practices for ADC synthesis, see the article "Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Synthesis", which outlines how this linker supports selective lysosomal payload release. The article "Mc-Val-Cit-PABC-PNP: ADC Peptide Linker for Cathepsin Cleavage" further details its suitability in constructing ADCs designed for lysosomal activation.

Protocol Parameters

• Solubility assay | ≥36.9 mg/mL in DMSO | Preparation of ADC linker-payload stock solutions | DMSO is the recommended solvent due to high solubility, ensuring maximal concentration and compatibility with organic-based conjugation chemistries | product dossier
• Storage condition | -20°C (solid) | Long-term stability before use | Maintaining at -20°C preserves integrity and prevents degradation of the Mc-Val-Cit-PABC-PNP linker during storage | product dossier
• Solution stability | Use immediately after preparation | ADC conjugation step | Solutions are not stable for extended storage; immediate use ensures maximum reactivity and prevents hydrolysis or decomposition of the linker | product dossier
• Water/ethanol solubility | Insoluble | Aqueous-based conjugation workflows | The linker is unsuitable for workflows that require dissolution in water or ethanol; alternative linkers should be considered for such protocols | product dossier
• Purity | 98.00% (as supplied) | Quality control for ADC synthesis | High-purity ensures minimal byproducts and batch-to-batch consistency in research settings | product dossier
• Recommended working concentration | Workflow-dependent, typically 1–10 mM in DMSO | ADC payload conjugation | Concentration should be optimized based on specific conjugation chemistry and payload characteristics | workflow recommendation

Workflow Setup and QC Checklist

1. Stock Solution Preparation: Dissolve Mc-Val-Cit-PABC-PNP in DMSO to prepare a concentrated stock (≥36.9 mg/mL). Avoid water or ethanol as solvents.
2. Storage: Store solid material at -20°C in a desiccated environment. Prepare solutions immediately prior to use and do not freeze/thaw dissolved material.
3. Conjugation Step: Add the DMSO-based stock solution directly to the antibody or payload under inert atmosphere conditions if required. Optimize molar ratios based on payload and antibody reactivity.
4. Reaction Monitoring: Use analytical HPLC or LC-MS to confirm successful conjugation and quantify product purity. Check for unreacted linker or payload.
5. Quality Control: Assess final ADC construct for residual DMSO content, aggregation, and integrity via SEC or SDS-PAGE. Verify that the linker is cleavable under lysosomal-mimicking conditions.
6. Documentation: Record batch numbers, solvent lots, and all reaction parameters for reproducibility and troubleshooting.

Common Failure Modes and Fixes

• Incomplete Dissolution: If linker does not dissolve fully in DMSO, gently warm the solution (up to room temperature) and vortex. Avoid introducing water, which can precipitate the linker.
• Low Conjugation Efficiency: Ensure the payload and antibody are fully solubilized and free of competing nucleophiles. Optimize molar ratios and check pH; use freshly prepared linker solution to maximize reactivity.
• Linker Degradation: If degradation is observed, verify that the stock solution was not stored for extended periods. Always make solutions fresh and limit exposure to moisture and light.
• ADC Instability: If the final ADC is unstable or aggregates, confirm that the organic solvent has been adequately removed post-conjugation and that buffer exchange was performed correctly.
• Ineffective Lysosomal Cleavage: Ensure that the ADC construct retains the full linker structure and has not undergone premature cleavage during synthesis or purification. Use cathepsin B activity assays under lysosomal pH to validate cleavage capacity.

Scope and Limitations

Mc-Val-Cit-PABC-PNP is intended strictly for scientific research and ADC construction in protocols that utilize organic solvents such as DMSO. Its design enables selective cytotoxic payload activation via lysosomal cathepsin B cleavage, making it optimal for targeted drug delivery research. However, this linker is unsuitable for diagnostic, medical, or in vivo applications, especially those requiring aqueous solubility or water-based buffers. Use in water-based protocols, or for any direct clinical or diagnostic purposes, is not supported. Researchers should verify that their workflow can accommodate organic-soluble linkers and that all regulatory requirements for research use are met.

Conclusion

Mc-Val-Cit-PABC-PNP provides a reliable cathepsin cleavable ADC peptide linker for constructing antibody-drug conjugates in targeted drug delivery research. Its high purity, DMSO solubility, and lysosomal cleavage specificity make it suitable for precise ADC workflows where payload release must be strictly controlled. For full product specifications and detailed handling recommendations, consult the APExBIO Mc-Val-Cit-PABC-PNP page. When used as directed, this linker supports reproducible, high-integrity ADC synthesis for research purposes only.